Lite Strategy (LITS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.15, -4.17% vs the prior close of $1.20.
- Volume 115.67K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LITS slides 4.2% to $1.15. Closed at $1.15, -4.17% vs the prior close of $1.20. Day range $1.13–$1.21, opened at $1.20.
LITS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LITS slides 4.2% to $1.15
- Closed at $1.15, -4.17% vs the prior close of $1.20. Day range $1.13–$1.21, opened at $1.20.
- Volume was 115.67K shares, 0.2x its 50-day average of 571.69K — lighter than usual.
- Price is +2.7% vs its 50-day average ($1.12) and +3.8% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.26; today's close sits at 29% of that range, 49.1% below the 52-week high.
Oct 15, 2026 — LITS rises 2.6% to $1.20
- Closed at $1.20, +2.56% vs the prior close of $1.17. Day range $1.13–$1.21, opened at $1.15.
- Volume was 317.90K shares, 0.6x its 50-day average of 567.19K — lighter than usual.
- Price is +7.6% vs its 50-day average ($1.12) and +8.2% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.26; today's close sits at 32% of that range, 46.9% below the 52-week high.
Oct 14, 2026 — LITS slides 3.3% to $1.17, 3 down days in a row
- Closed at $1.17, -3.31% vs the prior close of $1.21. Day range $1.15–$1.20, opened at $1.20.
- Volume was 278.70K shares, 0.5x its 50-day average of 564.63K — lighter than usual.
- Price is +5.3% vs its 50-day average ($1.11) and +5.4% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.26; today's close sits at 31% of that range, 48.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — LITS dips 0.8% to $1.21
- Closed at $1.21, -0.82% vs the prior close of $1.22. Day range $1.20–$1.24, opened at $1.23.
- Volume was 294.30K shares, 0.5x its 50-day average of 560.61K — lighter than usual.
- Price is +9.4% vs its 50-day average ($1.11) and +8.9% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.34; today's close sits at 32% of that range, 48.3% below the 52-week high.
Oct 12, 2026 — LITS slides 3.9% to $1.22
- Closed at $1.22, -3.94% vs the prior close of $1.27. Day range $1.21–$1.28, opened at $1.26.
- Volume was 271.30K shares, 0.5x its 50-day average of 556.49K — lighter than usual.
- Price is +10.7% vs its 50-day average ($1.10) and +9.8% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.97; today's close sits at 23% of that range, 58.9% below the 52-week high.
Oct 9, 2026 — LITS jumps 4.1% to $1.27
- Closed at $1.27, +4.10% vs the prior close of $1.22. Day range $1.24–$1.31, opened at $1.25.
- Volume was 539.90K shares, 1.0x its 50-day average of 547.82K.
- Price is +15.8% vs its 50-day average ($1.10) and +14.2% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.97; today's close sits at 25% of that range, 57.2% below the 52-week high.
Oct 8, 2026 — LITS slides 3.9% to $1.22 on 1.9x normal volume
- Closed at $1.22, -3.94% vs the prior close of $1.27. Day range $1.18–$1.30, opened at $1.30.
- Volume was 982.80K shares, 1.9x its 50-day average of 529.90K — unusually heavy trading.
- Price is +11.8% vs its 50-day average ($1.09) and +9.6% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.97; today's close sits at 23% of that range, 58.9% below the 52-week high.
Oct 7, 2026 — LITS slides 9.9% to $1.27
- Closed at $1.27, -9.93% vs the prior close of $1.41. Day range $1.27–$1.33, opened at $1.30.
- Volume was 786.80K shares, 1.5x its 50-day average of 516.11K.
- Price is +17.0% vs its 50-day average ($1.09) and +14.0% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.97; today's close sits at 25% of that range, 57.2% below the 52-week high.
Oct 6, 2026 — LITS rises 0.7% to $1.41
- Closed at $1.41, +0.71% vs the prior close of $1.40. Day range $1.37–$1.44, opened at $1.40.
- Volume was 493.80K shares, 1.0x its 50-day average of 511.37K.
- Price is +30.6% vs its 50-day average ($1.08) and +26.5% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.97; today's close sits at 32% of that range, 52.5% below the 52-week high.
Oct 5, 2026 — LITS rises 1.4% to $1.40
- Closed at $1.40, +1.45% vs the prior close of $1.38. Day range $1.36–$1.43, opened at $1.40.
- Volume was 432.50K shares, 0.9x its 50-day average of 505.96K.
- Price is +30.7% vs its 50-day average ($1.07) and +25.6% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.97; today's close sits at 31% of that range, 52.9% below the 52-week high.
Oct 2, 2026 — LITS ends flat (+0.0%) to $1.38 on 2.1x normal volume
- Closed at $1.38, +0.00% vs the prior close of $1.38. Day range $1.37–$1.50, opened at $1.47.
- Volume was 1.01M shares, 2.1x its 50-day average of 488.24K — unusually heavy trading.
- Price is +29.9% vs its 50-day average ($1.06) and +23.8% vs its 200-day average ($1.11).
- 52-week range $0.69–$2.97; today's close sits at 30% of that range, 53.5% below the 52-week high.
LITS latest news & SEC filings
Every SEC filing by or about LITS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 28, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 28, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Net income: -$71.15M (prior year -$15.95M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$2.06 (prior year -$2.39) (loss narrowed vs Jun 30, 2025)
Aug 3, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Flynn James P bought 25,000 shares at $0.86 (≈$21.50K) on Jun 24, 2026
- Flynn James P bought 25,000 shares at $0.86 (≈$21.50K) on Jun 24, 2026
- Flynn James P bought 25,000 shares at $0.86 (≈$21.50K) on Jun 24, 2026
- Flynn James P bought 25,000 shares at $0.86 (≈$21.50K) on Jun 24, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade LITS
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Feb 17, 2026, May 13, 2025. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.84% (largest 21.2%). That is a volatile stock.
- Liquidity: about 945.20K shares (≈$1.09M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.15 vs a range of $0.69–$2.26 (29% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 4 sales; latest: James P Flynn bought 25,000 shares on Jun 24, 2026.
- Latest filings: 10-K Sep 28, 2026; 8-K Jul 30, 2026; 8-K Jul 24, 2026.
- Share count: 30.41M shares outstanding (Sep 22, 2026), -14.7% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LITS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.20 | 1.21 | 1.13 | 1.15 | 115.67K |
| Oct 15, 2026 | 1.15 | 1.21 | 1.13 | 1.20 | 317.90K |
| Oct 14, 2026 | 1.20 | 1.20 | 1.15 | 1.17 | 278.70K |
| Oct 13, 2026 | 1.23 | 1.24 | 1.20 | 1.21 | 294.30K |
| Oct 12, 2026 | 1.26 | 1.28 | 1.21 | 1.22 | 271.30K |
| Oct 9, 2026 | 1.25 | 1.31 | 1.24 | 1.27 | 539.90K |
| Oct 8, 2026 | 1.30 | 1.30 | 1.18 | 1.22 | 982.80K |
| Oct 7, 2026 | 1.30 | 1.33 | 1.27 | 1.27 | 786.80K |
| Oct 6, 2026 | 1.40 | 1.44 | 1.37 | 1.41 | 493.80K |
| Oct 5, 2026 | 1.40 | 1.43 | 1.36 | 1.40 | 432.50K |
| Oct 2, 2026 | 1.47 | 1.50 | 1.37 | 1.38 | 1.01M |
| Oct 1, 2026 | 1.31 | 1.41 | 1.28 | 1.38 | 1.04M |
| Sep 30, 2026 | 1.38 | 1.40 | 1.32 | 1.32 | 329.00K |
| Sep 29, 2026 | 1.35 | 1.41 | 1.34 | 1.38 | 627.20K |
| Sep 28, 2026 | 1.40 | 1.46 | 1.32 | 1.36 | 951.00K |
| Sep 25, 2026 | 1.43 | 1.53 | 1.37 | 1.44 | 2.26M |
| Sep 24, 2026 | 1.33 | 1.54 | 1.31 | 1.43 | 5.37M |
| Sep 23, 2026 | 1.28 | 1.31 | 1.17 | 1.18 | 584.20K |
| Sep 22, 2026 | 1.26 | 1.32 | 1.24 | 1.30 | 609.40K |
| Sep 21, 2026 | 1.20 | 1.33 | 1.08 | 1.28 | 1.61M |
About Lite Strategy
Lite Strategy (LITS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1262104.
LITS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Frederick W Driscoll | Director | Nov 18, 2025 |
| Justin J. File | CEO, CFO and Secretary | Feb 12, 2026 |
| James P Flynn | Director | Jun 25, 2026 |
| Nicholas Glover | Director | Nov 19, 2025 |
| Charles Benjamin Lee | Director | Oct 6, 2025 |
| Joshua Riezman | Director | Nov 18, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Justin J. File | CEO, CFO and Secretary | Feb 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 24, 2026 | James P Flynn | Buy | 25,000 | $0.86 |
| Jun 24, 2026 | James P Flynn | Buy | 25,000 | $0.86 |
| Jun 24, 2026 | James P Flynn | Buy | 25,000 | $0.86 |
| Jun 24, 2026 | James P Flynn | Buy | 25,000 | $0.86 |
| Dec 19, 2025 | James P Flynn | Buy | 70,000 | $1.40 |
| Dec 19, 2025 | James P Flynn | Buy | 70,000 | $1.40 |
| Dec 19, 2025 | James P Flynn | Buy | 70,000 | $1.40 |
| Dec 19, 2025 | James P Flynn | Buy | 70,000 | $1.40 |
| Dec 18, 2025 | Alexander Schornstein | Sale | 690,611 | $1.37 |
| Dec 18, 2025 | Alexander Schornstein | Sale | 690,611 | $1.37 |
| Dec 18, 2025 | Alexander Schornstein | Sale | 690,611 | $1.37 |
| Dec 18, 2025 | Alexander Schornstein | Sale | 690,611 | $1.37 |
| Nov 19, 2025 | James P Flynn | Buy | 12,100 | $1.88 |
| Nov 19, 2025 | James P Flynn | Buy | 12,100 | $1.88 |
| Nov 19, 2025 | James P Flynn | Buy | 12,100 | $1.88 |
LITS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | — | $-71.15M | -2.06 | $-9.12M |
| Jun 30, 2025 | $0 | $-15.95M | -2.39 | $-20.84M |
| Jun 30, 2024 | $65.30M | $18.00M | 2.67 | $-50.47M |
| Jun 30, 2023 | $48.82M | $-32.00M | -4.78 | $-52.48M |
| Jun 30, 2022 | $40.70M | $-54.45M | -9.99 | $-48.75M |
Latest balance sheet: total assets $42.69M, total liabilities $1.07M, cash $5.71M (as of Jun 30, 2026).
LITS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $0.99 |
| May 13, 2026 | 8-K Item 2.02 (results) | $1.18 |
| Feb 17, 2026 | 8-K Item 2.02 (results) | $1.10 |
| May 13, 2025 | 8-K Item 2.02 (results) | $2.09 |
| Feb 12, 2025 | 8-K Item 2.02 (results) | $2.66 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $3.01 |
| Sep 19, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 13, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
| Sep 26, 2023 | 8-K Item 2.02 (results) | — |
| May 11, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LITS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.